Source link : https://newshealth.biz/health-news/fda-expands-stelara-approval-liver-cancer-blood-test-pharmacotherapy-for-masld/
The FDA expanded the approval of ustekinumab (Stelara) in Crohn’s disease to include the treatment of kids as young as 2 years, Johnson & Johnson announced. High clinical remission rates (98%) at approximately 5 years were reported with guselkumab (Tremfya) maintenance in Crohn’s disease, long-term follow-up of the phase II GALAXI-1 trial showed. (Inflammatory Bowel […]
The post FDA Expands Stelara Approval; Liver Cancer Blood Test; Pharmacotherapy for MASLD first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-07 14:47:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8